Name: NURS6630N Pharmacology Final Exam Week 11 With Answers (76 Solved Questions)
Brand: Walden University
Price: 3 USD
Availability: InStock
Author: Ruby Reed

Course
NURS-6630N
Test
Week 11 Final Exam
 Question 1
0 out of 1 points
A patient diagnosed with obsessive compulsive disorder has been
taking a high-dose SSRI and is participating in therapy twice a week.
He reports an inability to carry out responsibilities due to consistent
interferences of his obsessions and compulsions. The PMHNP knows
that the next step would be which of the following?
Selected Answer: B.
Decrease his SSRI and add an MAOI.
 Question 2
0 out of 1 points
Which statement best describes a pharmacological approach to treating
patients for impulsive aggression?
Selected
Answer:
B.
Atypical antipsychotics can increase subcortical
dopaminergic stimulation.

 Question 3
1 out of 1 points
The PMHNP evaluates a patient presenting with symptoms of
dementia. Before the PMHNP considers treatment options, the patient
must be assessed for other possible causes of dementia. Which of the
following answers addresses both possible other causes of dementia
and a rational treatment option for Dementia?
Selected
Answer:
B.
Possible other causes: hypothyroidism, adrenal
insufficiency, hyperparathyroidism
Possible treatment option: donepezil
 Question 4
1 out of 1 points
An 80-year-old female patient diagnosed with Stage II Alzheimer’s has
a history of irritable bowel syndrome. Which cholinergic drug may be
the best choice for treatment given the patient’s gastrointestinal
problems?
Selected Answer: A.
Donepezil (Aricept)
 Question 5
0 out of 1 points
The PMHNP is teaching parents about their child’s new prescription
for Ritalin. What will the PMHNP include in the teaching?
Selected Answer: D.
There will be continued effects into the evening.

 Question 6
1 out of 1 points
The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic
pain. How does the PMHNP anticipate the drug to work?
Selected
Answer:
A.
It will bind to the alpha-2-delta ligand subunit of
voltage-sensitive calcium channels.
 Question 7
1 out of 1 points
An opioid-naive patient is taking MS Contin (morphine sulfate) to treat
his pain that is secondary to cancer. Under what circumstances would
the PMHNP order naloxone (Narcan) IM/SQ?
Selected
Answer:
D.
The patient’s vital signs are 98.4F temp, 88 pulse,
104/62 blood pressure, and 8 respirations.
 Question 8
1 out of 1 points
A patient is prescribed D-methylphenidate, 10-mg extended-release
capsules. What should the PMHNP include when discussing the side
effects with the patient?
Selected Answer: C.
The medication can affect your blood pressure.
 Question 9
1 out of 1 points
A young patient is prescribed Vyvanse. During the follow-up
appointment, which comment made by the patient makes the PMHNP
think that the dosing is being done incorrectly?

Selected Answer: B.
“I am unable to fall asleep at night.”
 Question 10
1 out of 1 points
A patient recovering from shingles presents with tenderness and
sensitivity to the upper back. He states it is bothersome to put a shirt on
most days. This patient has end stage renal disease (ESRD) and is
scheduled to have hemodialysis tomorrow but states that he does not
know how he can lie in a recliner for 3 hours feeling this
uncomfortable. What will be the PMHNP’s priority?
Selected Answer: C.
Prescribe lidocaine 5%
 Question 11
0 out of 1 points
A 63-year-old patient presents with the following symptoms. The
PMHNP determines which set of symptoms warrant prescribing a
medication? Select the answer that is matched with an appropriate
treatment.
Selected
Answer:
C.
Reduced ability to find the correct word is most
problematic, and an appropriate treatment option would
be memantine.
 Question 12
1 out of 1 points
The PMHNP is caring for a patient who openly admitted to drinking a
quart of vodka daily. Prior to prescribing this patient disulfiram
(Antabuse), it is important for the PMHNP to:

Selected
Answer:
A.
Evaluate the patient’s willingness to abstain from
alcohol
 Question 13
0 out of 1 points
A PMHNP supervisor is discussing with a nursing student how
stimulants and noradrenergic agents assist with ADHD symptoms.
What is the appropriate response?
Selected
Answer:
A.
They both increase signal strength output dopamine
(DA) and norepinephrine (NE).
 Question 14
1 out of 1 points
The PMHNP is assessing a female patient who has been taking
lamotrigine (Lamictal) for migraine prophylaxis. After discovering that
the patient has reached the maximum dose of this medication, the
PMHNP decides to change the patient’s medication to zonisamide
(Zonegran). In addition to evaluating this patient’s day-to-day
activities, what should the PMHNP ensure that this patient
understands?
Selected
Answer:
D.
This medication has unwanted side effects such as
sedation, lack of coordination, and drowsiness.
 Question 15
0 out of 0 points
When completing this exam, did you comply with Walden University’s
Code of Conduct including the expectations for academic integrity?

Loading page 6...

Selected Answer: Yes
 Question 16
1 out of 1 points
The PMHNP is teaching a patient with a sleep disorder about taking
diphenhydramine (Benadryl). The patient is concerned about the side
effects of the drug. What can the PMHNP teach the patient about this
treatment approach?
Selected Answer: B.
“It can cause blurred vision.”
 Question 17
1 out of 1 points
The PMHNP is performing a quality assurance peer review of the chart
of another PMHNP. Upon review, the PMHNP reviews the chart of an
older adult patient in long-term care facility who has chronic insomnia.
The chart indicates that the patient has been receiving hypnotics on a
nightly basis. What does the PMHNP find problematic about this
documentation?
Selected
Answer:
B.
Hypnotics have prolonged half-lives that can cause drug
accumulation in the elderly.
 Question 18
1 out of 1 points
A 14-year-old patient is prescribed Strattera and asks when the
medicine should be taken. What does the PMHNP understand
regarding the drug’s dosing profile?

Loading page 7...

Selected Answer: B.
The patient will have one or two doses a day.
 Question 19
1 out of 1 points
The PMHNP is assessing a patient who presents with elevated levels of
brain amyloid as noted by positron emission tomography (PET). What
other factors will the PMHNP consider before prescribing medication
for this patient, and what medication would the PMHNP want to avoid
given these other factors?
Selected Answer: D.
Both “A” & “B”
 Question 20
1 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who
is receiving an initial prescription for D-amphetamine. The PMHNP
demonstrates appropriate prescribing practices when she prescribes the
following dose:
Selected Answer: A.
The child will be prescribed 2.5 mg.
 Question 21
1 out of 1 points
A 9-year-old female patient presents with symptoms of both attention
deficit hyperactivity disorder (ADHD) and oppositional defiant
disorder. In evaluating her symptoms, the PMHNP determines that
which of the following medications may be beneficial in augmenting
stimulant medication?
Selected Answer: C.
Guanfacine ER (Intuniv)

Loading page 8...

NURS6630N Pharmacology Final Exam Week 11 With Answers (76 Solved Questions)

Study Now!

Document Details

Related Documents

2019 NURS-6630N Nursing Diagnosis Week 11 Final Exam With Answers (76 Solved Questions)

The Evolution of Nursing Science: Key Theories and Their Impact on Patient Care

Pediatric Gastrointestinal Disorders: Pathophysiology, Clinical Manifestations, Treatments, and Nursing Management

NUR/443 Cost and Effects of Performance Feedback and Nurse Case Management

NRS-427V Week 2 Epidemiology Paper

NRS-427V Week 2 Epidemiology and Communicable Diseases Paper

NR660 Capstone Chamberlain College of Nursing Evaluation of epidemiology Problem

NUR440 Case Study 5 Acute Renal Failure

Chamberlain College of Nursing NR503 Population Health, Epidemiology, & Statistical Principles

Nursing Entrance Exams Test Easy (2019)

Company

Explore

Study Tools